Murray Dallan sold SRPT
March 3, 2025 · Form 4 insider transaction
Murray Dallan sold 711 shares of Sarepta Therapeutics, Inc. at $103.77 per share, a transaction worth $73.8K. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
711
Price
$103.77
Total value
$73.8K
InsiderMurray Dallan
RoleOfficer
SecurityCommon Stock
Transaction codeF: Shares withheld for taxes
Transaction dateMarch 3, 2025
Filing dateMarch 4, 2025
Shares owned after21,506
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Shares were sold by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 1, 2024.; Amount of Securities Beneficially Owned includes 194 shares purchased under the Company's registered Employee Stock Purchase Plan on February 28, 2025.